Artwork

Inhoud geleverd door Olumide Ogunsanwo and Bankole Makanju, Olumide Ogunsanwo, and Bankole Makanju. Alle podcastinhoud, inclusief afleveringen, afbeeldingen en podcastbeschrijvingen, wordt rechtstreeks geüpload en geleverd door Olumide Ogunsanwo and Bankole Makanju, Olumide Ogunsanwo, and Bankole Makanju of hun podcastplatformpartner. Als u denkt dat iemand uw auteursrechtelijk beschermde werk zonder uw toestemming gebruikt, kunt u het hier beschreven proces https://nl.player.fm/legal volgen.
Player FM - Podcast-app
Ga offline met de app Player FM !

#38: 54gene - How the HealthTech platform is building diverse datasets to improve diagnostic and treatment outcomes across Africa

1:58:15
 
Delen
 

Manage episode 303070928 series 2712808
Inhoud geleverd door Olumide Ogunsanwo and Bankole Makanju, Olumide Ogunsanwo, and Bankole Makanju. Alle podcastinhoud, inclusief afleveringen, afbeeldingen en podcastbeschrijvingen, wordt rechtstreeks geüpload en geleverd door Olumide Ogunsanwo and Bankole Makanju, Olumide Ogunsanwo, and Bankole Makanju of hun podcastplatformpartner. Als u denkt dat iemand uw auteursrechtelijk beschermde werk zonder uw toestemming gebruikt, kunt u het hier beschreven proces https://nl.player.fm/legal volgen.

Overview: Today, we’re going to talk about 54gene - the genomics HealthTech company. We’ll explore the 54gene story across 6 areas:

  1. African Health care status & context
  2. 54gene early history
  3. Fundraising & Growth
  4. Product & monetization strategy
  5. Competitive positioning & potential exit options
  6. Overall outlook.

This episode was recorded on Sep 19, 2021

Companies discussed: 54gene, llumina, African Centre of Excellence for Genomics of Infectious Diseases, Y Combinator (YC), 50 Years, Bill & Melinda Gates Foundation, Gilead, IMS Health, Broad Institute, Novartis, Cathay AfricInvest, Helium Health & mPharma

Business concepts discussed: Genomics, Capacity development / Local knowledge development, Healthcare technology, Health insurance coverage, commercial biobanks & public policy

Conversation highlights:

  • (00:54) - Why we’re talking about 54Gene today
  • (06:25) - Context on Healthcare and Genomics in Africa
  • (27:02) - 54Gene founding and early history
  • (34:13) - Fundraising and early growth - Seed, Series A, Series B
  • (54:15) - Product and monetization strategy
  • (1:11:00) - 54Gene capacity building
  • (1:17:00) - Competition in this space, exit opportunities
  • (1:30:39) - Olumide’s overall thoughts and outlook
  • (1:42:38) - Bankole’s overall thoughts and outlook
  • (1:56:03) - Recommendations and small wins

Olumide’s recommendations & small wins:

Bankole’s recommendations & small wins:

Listeners: We’d love to hear from you. Email info@afrobility.com with feedback!

Founders: We'd love to hear about what you're working on, email us at info@afrobility.com

Investors: We'd also love to link up with you to drive the ecosystem forward. Contact us at info@afrobility.com

Join our insider mailing list where we get feedback on new episodes & find all episodes at Afrobility.com

  continue reading

79 afleveringen

Artwork
iconDelen
 
Manage episode 303070928 series 2712808
Inhoud geleverd door Olumide Ogunsanwo and Bankole Makanju, Olumide Ogunsanwo, and Bankole Makanju. Alle podcastinhoud, inclusief afleveringen, afbeeldingen en podcastbeschrijvingen, wordt rechtstreeks geüpload en geleverd door Olumide Ogunsanwo and Bankole Makanju, Olumide Ogunsanwo, and Bankole Makanju of hun podcastplatformpartner. Als u denkt dat iemand uw auteursrechtelijk beschermde werk zonder uw toestemming gebruikt, kunt u het hier beschreven proces https://nl.player.fm/legal volgen.

Overview: Today, we’re going to talk about 54gene - the genomics HealthTech company. We’ll explore the 54gene story across 6 areas:

  1. African Health care status & context
  2. 54gene early history
  3. Fundraising & Growth
  4. Product & monetization strategy
  5. Competitive positioning & potential exit options
  6. Overall outlook.

This episode was recorded on Sep 19, 2021

Companies discussed: 54gene, llumina, African Centre of Excellence for Genomics of Infectious Diseases, Y Combinator (YC), 50 Years, Bill & Melinda Gates Foundation, Gilead, IMS Health, Broad Institute, Novartis, Cathay AfricInvest, Helium Health & mPharma

Business concepts discussed: Genomics, Capacity development / Local knowledge development, Healthcare technology, Health insurance coverage, commercial biobanks & public policy

Conversation highlights:

  • (00:54) - Why we’re talking about 54Gene today
  • (06:25) - Context on Healthcare and Genomics in Africa
  • (27:02) - 54Gene founding and early history
  • (34:13) - Fundraising and early growth - Seed, Series A, Series B
  • (54:15) - Product and monetization strategy
  • (1:11:00) - 54Gene capacity building
  • (1:17:00) - Competition in this space, exit opportunities
  • (1:30:39) - Olumide’s overall thoughts and outlook
  • (1:42:38) - Bankole’s overall thoughts and outlook
  • (1:56:03) - Recommendations and small wins

Olumide’s recommendations & small wins:

Bankole’s recommendations & small wins:

Listeners: We’d love to hear from you. Email info@afrobility.com with feedback!

Founders: We'd love to hear about what you're working on, email us at info@afrobility.com

Investors: We'd also love to link up with you to drive the ecosystem forward. Contact us at info@afrobility.com

Join our insider mailing list where we get feedback on new episodes & find all episodes at Afrobility.com

  continue reading

79 afleveringen

Semua episod

×
 
Loading …

Welkom op Player FM!

Player FM scant het web op podcasts van hoge kwaliteit waarvan u nu kunt genieten. Het is de beste podcast-app en werkt op Android, iPhone en internet. Aanmelden om abonnementen op verschillende apparaten te synchroniseren.

 

Korte handleiding

Luister naar deze show terwijl je op verkenning gaat
Spelen